G01N 2405/06
Glycophospholipids
Official title: Glycophospholipids, e.g. phosphatidyl inositol
G01N2405/06 (Glycophospholipids) appears on 22 US grants and 51 published applications in this corpus.
Search patents in G01N- Granted patents
- 22
- Published applications
- 51
- Assignees
- 46
- Inventors
- 109
- Latest grant
- 23 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 1 |
| 2002 | 2 | 0 |
| 2003 | 1 | 2 |
| 2004 | 0 | 0 |
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 1 |
| 2008 | 0 | 2 |
| 2009 | 1 | 0 |
| 2010 | 1 | 1 |
| 2011 | 1 | 0 |
| 2012 | 0 | 1 |
| 2013 | 0 | 2 |
| 2014 | 1 | 3 |
| 2015 | 1 | 3 |
| 2016 | 1 | 2 |
| 2017 | 2 | 3 |
| 2018 | 0 | 4 |
| 2019 | 1 | 2 |
| 2020 | 2 | 3 |
| 2021 | 1 | 3 |
| 2022 | 0 | 4 |
| 2023 | 1 | 3 |
| 2024 | 0 | 3 |
| 2025 | 2 | 5 |
| 2026 | 0 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compositions and methods for trehalose phospholipids23 Dec 2025US 12,503,482 B2Rijksuniversiteit Groningen
- Lipidomic biomarkers for identification of high-risk coronary artery disease patients8 Apr 2025US 12,270,816 B2Zora Biosciences Oy
- Method and associated device for rapid detection of target biomolecules with enhanced sensitivity1 Aug 2023US 11,714,084 B2General Electric Company
- Lipidomic biomarkers for identification of high-risk coronary artery disease patients23 Mar 2021US 10,955,427 B2Zora Biosciences Oy
- Method and associated device for rapid detection of target biomolecules with enhanced sensitivity17 Nov 2020US 10,837,962 B2General Electric Company
- Compositions and methods for trehalose phospholipids19 Mar 2026US 2026/0078140 A1Rijksuniversiteit Groningen
- Methods of diagnosis and guiding treatment of vulvovaginal symptoms and female sexual dysfunction8 Jan 2026US 2026/0009800 A1Arizona Board of Regents on Behalf of the University of Arizona
- Diagnostic signature9 Oct 2025US 2025/0314671 A1BCAL Diagnostics Limited
- Phosphatidylserine targeting molecule combined with memory t cell antigen for therapeutic, diagnostic and adjuvant use18 Sep 2025US 2025/0289907 A1Rutgers, The State University of New Jersey
- Quantitative lipidomic analysis, methods and uses thereof5 Jun 2025US 2025/0180508 A1McMaster University
Most cited
By later US patents
- Determination of biological characteristics of embryos fertilized in vitro by assaying for bioactive lipids in culture media142US 6,489,135 B1AtairginTechnologies, Inc. · 2002
- Nucleic acid-coupled colorimetric analyte detectors41US 6,306,598 B1The Regents of the University of California · 2001
- Colorimetric glycopolythiophene biosensors25US 6,660,484 B2The Regents of the University of California · 2003
- Direct colorimetric detection of biocatalysts22US 6,468,759 B1The Regents of the University of California · 2002
- Method for detecting phosphatidylinositol through binding to Concanavalin A10US 4,863,874 AThe United States of America as represented by the Secretary of the Army · 1989